Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Matteson

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
The Annals of Otology, Rhinology, and Laryngology|August 29, 2000
Use of methotrexate for autoimmune hearing lossE L Matteson, O Tirzaman, G W Facer, et al.
Clinical and Experimental Rheumatology|April 10, 2007
Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literatureJ B Martinez, J S Valero, A J Bautista, et al.
Arthritis and Rheumatism|April 28, 2001
Open trial of methotrexate as treatment for autoimmune hearing lossE L Matteson, D A Fabry, G W Facer, et al.
Mayo Clinic Proceedings|June 8, 2001
Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, MinnesotaS R Pillemer, E L Matteson, L T Jacobsson, et al.
Archives of Dermatology|April 1, 1989
Cyclosporine in the treatment of psoriatic arthritisA K Gupta, E L Matteson, C N Ellis, et al.
Rheumatology (Oxford, England)|June 20, 2006
Citrullination in extra-articular manifestations of rheumatoid arthritisT Bongartz, T Cantaert, S R Atkins, et al.
Scandinavian Journal of Rheumatology|July 7, 2021
Outpatient healthcare utilization among incident cases of systemic sclerosis: results from a population-based US cohort (1988-2016)C M Coffey, A S Sandhu, C S Crowson, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical FolatescanE L Matteson, V J Lowe, F G Prendergast, et al.
Arthritis and Rheumatism|August 1, 1993
Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial diseaseC W Castor, P C Andrews, R D Swartz, et al.
British Journal of Rheumatology|March 1, 1996
CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging studyJ D Isaacs, V K Manna, N Rapson, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
The Annals of Otology, Rhinology, and Laryngology|August 29, 2000
Use of methotrexate for autoimmune hearing lossE L Matteson, O Tirzaman, G W Facer, et al.
Clinical and Experimental Rheumatology|April 10, 2007
Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literatureJ B Martinez, J S Valero, A J Bautista, et al.
Arthritis and Rheumatism|April 28, 2001
Open trial of methotrexate as treatment for autoimmune hearing lossE L Matteson, D A Fabry, G W Facer, et al.
Mayo Clinic Proceedings|June 8, 2001
Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, MinnesotaS R Pillemer, E L Matteson, L T Jacobsson, et al.
Archives of Dermatology|April 1, 1989
Cyclosporine in the treatment of psoriatic arthritisA K Gupta, E L Matteson, C N Ellis, et al.
Rheumatology (Oxford, England)|June 20, 2006
Citrullination in extra-articular manifestations of rheumatoid arthritisT Bongartz, T Cantaert, S R Atkins, et al.
Scandinavian Journal of Rheumatology|July 7, 2021
Outpatient healthcare utilization among incident cases of systemic sclerosis: results from a population-based US cohort (1988-2016)C M Coffey, A S Sandhu, C S Crowson, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical FolatescanE L Matteson, V J Lowe, F G Prendergast, et al.
Arthritis and Rheumatism|August 1, 1993
Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial diseaseC W Castor, P C Andrews, R D Swartz, et al.
British Journal of Rheumatology|March 1, 1996
CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging studyJ D Isaacs, V K Manna, N Rapson, et al.
Pageof 9